346 EXCESSIVE VISCERAL FAT ACCUMULATION PLAYS BOTH ROLES AS THE FIRST AND SECOND HIT IN THE PATHOGENESIS AND PROGRESSION OF NONALCOHOLIC FATTY LIVER DISEASEE. Ishibashi; Y. Eguchi; T. Mizuta; Y. Kitajima; Y. Kawaguchi; T. Kuwashiro; S. Matsunaga; Y. Oda; I. Ozaki; K. Anzai; R. Iwakiri; N. Ono; T. Eguchi; S. Koizumi; K. Fujimoto · 2010

833 THE DECREASE OF INTRA-MUSCULAR ADIPOSE TISSUE CONTENT IS AN INDEPENDENT TARGET FOR TREATMENT OF NONALCOHOLIC STEATOHEPATITIS/NONALCOHOLIC FATTY LIVER DISEASEY. Eguchi; Y. Kitajima; M. Ono; T. Mizuta; E. Ishibashi; I. Ozaki; Y. Oda; N. Ono; T. Eguchi; K. Anzai; R. Iwakiri; S. Koizumi; K. Fujimoto · 2011

Granular cells in the juxtaglomerular apparatus in perinatal ratsY. Eguchi; Michiko Yamakawa; Y. Morikawa; Y. Hashimoto · 1975

992 THE CHANGE IN SERUM AMINOTRANSFERASE LEVEL ACHIEVED BY WEIGHT REDUCTION PREDICTS THE IMPROVEMENT OF LIVER STEATOSIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASEE. Ishibashi; Y. Eguchi; T. Mizuta; Y. Kitajima; N. Oza; S. Nakashita; A. Matsunobu; H. Takahashi; Y. Kawaguchi; R. Iwakiri; I. Ozaki; T. Eguchi; N. Ono; K. Fujimoto · 2009

998 SERUM TRIGLYCERIDE LEVEL AS A METABOLIC RISK FACTOR WAS INDEPENDENTLY ASSOCIATED WITH SERUM AMINOTRANSFERASE LEVEL IN NONALCOHOLIC FATTY LIVER DISEASE PATIENTS WITH CENTRAL OBESITYE. Ishibashi; Y. Eguchi; T. Mizuta; Y. Kitajima; N. Oza; S. Nakashita; A. Matsunobu; H. Takahashi; Y. Kawaguchi; I. Ozaki; R. Iwakiri; T. Eguchi; N. Ono; K. Fujimoto · 2009

Serum cytokines in patients with rheumatoid arthritisS. Sakito; Y. Ueki; K. Eguchi; Y. Kawabe; S. Nagataki · 1995

Rheumatoid factors and glomerulonephritisM. MIYAZAKI; M. ENDOH; T. SUGA; N. YANO; T. KURAMOTO; Y. MATSUMOTO; K. EGUCHI; M. YAGAME; M. MIURA; Y. NOMOTO; H. SAKAI · 1990

Discrepancy of Cross Sections inpdBreakup Reactions atEp= 250S. Kuroita; K. Sagara; Y. Eguchi; K. Yashima; T. Shishido; T. Yabe; M. Dozono; Y. Yamada; T. Wakasa; T. Noro; H. Matsubara; J. Zenihiro; A. Tamii; H. Okamura; K. Hatanaka; T. Saito; Y. Maeda; H. Kamada; Y. Tameshige · 2011